Madison Muller

Novo is suing on the grounds of patent infringement, which is something we haven't seen before.

Novo and Lilly have both filed lawsuits against compounding pharmacies, telehealth companies, med spas that are selling these knockoff versions of the drugs, but they haven't gone after anyone for patent infringement yet.

So this is actually the drug semaglutide, which is the active ingredient in both Ozempic and Wagovi.

Novo is saying that HIMS is violating that patent in the United States.

Novo is suing on the grounds of patent infringement, which is something we haven't seen before.

Novo and Lilly have both filed lawsuits against compounding pharmacies, telehealth companies, med spas that are selling these knockoff versions of the drugs, but they haven't gone after anyone for patent infringement yet.

So this is actually the drug semaglutide, which is the active ingredient in both Ozempic and Wagovi.

Novo is saying that HIMS is violating that patent in the United States.